Literature DB >> 26266488

TCTP Expression After Rat Spinal Cord Injury: Implications for Astrocyte Proliferation and Migration.

Jianbing Ren1, Xingxing Mao2, Minghao Chen2, Weidong Zhang2, Yang Liu2, Chengwei Duan3, Haiyan Zhang3, Chi Sun2, Weijie Wu2, Xinjian Zhu1, Jianbing Ge1, Weidong Tao1, Youhua Wang4, Hongjian Lu5.   

Abstract

Translationally controlled tumor protein (TCTP) is a ubiquitous and highly conserved protein which plays a role in cell proliferation and growth, apoptosis, and cell cycle regulation. However, its expression and function in spinal cord injury (SCI) are still unknown. Here, we demonstrated that expression of TCTP was dynamic changed after acute spinal cord injury. Our results showed that TCTP gradually increased, reached a peak at 3 day, and then declined to basal levels at 14 days after spinal cord injury. Upregulation of TCTP was accompanied with an increase in the levels of proliferation proteins such as PCNA. Immunofluorescent labeling also showed that TCTP located in astrocytes and traumatic SCI induced TCTP colocalizated with PCNA. These results indicated that TCTP might play an important role in astrocyte proliferation. To further probe the role of TCTP, TCTP-specific siRNA-transfected astrocytes showed significant decrease of primary astrocyte proliferation. Surprisingly, TCTP knockdown also reduced primary astrocyte migration, as the reorganization of microtubules and F-actin was disturbed after siRNA transfection. All above indicated that TCTP might play a crucial role in astrocyte proliferation and migration. Collectively, our data suggested that TCTP might play important roles in CNS pathophysiology after SCI.

Entities:  

Keywords:  Astrocyte; Migration; Proliferation; Spinal cord injury; TCTP

Mesh:

Substances:

Year:  2015        PMID: 26266488     DOI: 10.1007/s12031-015-0628-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  25 in total

Review 1.  Regeneration beyond the glial scar.

Authors:  Jerry Silver; Jared H Miller
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

2.  The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar.

Authors:  Philippe P Monnier; Ana Sierra; Jan M Schwab; Sigrid Henke-Fahle; Bernhard K Mueller
Journal:  Mol Cell Neurosci       Date:  2003-03       Impact factor: 4.314

3.  Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury.

Authors:  Ulrika Wilhelmsson; Eric A Bushong; Diana L Price; Benjamin L Smarr; Van Phung; Masako Terada; Mark H Ellisman; Milos Pekny
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

Review 4.  Role of extracellular factors in axon regeneration in the CNS: implications for therapy.

Authors:  Noreen M Gervasi; Jessica Cf Kwok; James W Fawcett
Journal:  Regen Med       Date:  2008-11       Impact factor: 3.806

5.  Translationally controlled tumor protein is a target of tumor reversion.

Authors:  Marcel Tuynder; Giusy Fiucci; Sylvie Prieur; Alexandra Lespagnol; Anne Géant; Séverine Beaucourt; Dominique Duflaut; Stéphanie Besse; Laurent Susini; Jean Cavarelli; Dino Moras; Robert Amson; Adam Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

6.  A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner.

Authors:  Sung Ho Chen; Peih-Shan Wu; Chiang-Hung Chou; Yu-Ting Yan; Hsuan Liu; Shih-Yen Weng; Hsin-Fang Yang-Yen
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

Review 7.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

8.  Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury.

Authors:  Kimberly R Byrnes; Bogdan A Stoica; Stanley Fricke; Simone Di Giovanni; Alan I Faden
Journal:  Brain       Date:  2007-08-09       Impact factor: 13.501

9.  Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activity.

Authors:  Felice Arcuri; Stefania Papa; Antonietta Carducci; Roberta Romagnoli; Sabrina Liberatori; Maria Giovanna Riparbelli; Jean-Charles Sanchez; Piero Tosi; Maria Teresa del Vecchio
Journal:  Prostate       Date:  2004-07-01       Impact factor: 4.104

10.  Translationally controlled tumor protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis.

Authors:  Seong-Yeon Bae; Hyun Jung Kim; Kong-Joo Lee; Kyunglim Lee
Journal:  Sci Rep       Date:  2015-01-27       Impact factor: 4.379

View more
  5 in total

1.  Downregulation of USP4 Promotes Activation of Microglia and Subsequent Neuronal Inflammation in Rat Spinal Cord After Injury.

Authors:  Xingjie Jiang; Mingchen Yu; Yiqing Ou; Yong Cao; Yu Yao; Ping Cai; Feng Zhang
Journal:  Neurochem Res       Date:  2017-07-28       Impact factor: 3.996

Review 2.  Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

Authors:  Decha Pinkaew; Ken Fujise
Journal:  Adv Clin Chem       Date:  2017-08-07       Impact factor: 5.394

Review 3.  The role of Wnt/mTOR signaling in spinal cord injury.

Authors:  Peng Cheng; Hai-Yang Liao; Hai-Hong Zhang
Journal:  J Clin Orthop Trauma       Date:  2022-01-04

Review 4.  Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects.

Authors:  Junying Gao; Yan Ma; Guiwen Yang; Guorong Li
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

Review 5.  Beneficial Effects of Resveratrol-Mediated Inhibition of the mTOR Pathway in Spinal Cord Injury.

Authors:  Jingying Zhou; Xue Huo; Benson O A Botchway; Luyao Xu; Xiaofang Meng; Songou Zhang; Xuehong Liu
Journal:  Neural Plast       Date:  2018-03-26       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.